Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.
about
A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end pointsImaging of HCC-Current State of the ArtAdded Value of Assessing Adnexal Masses with Advanced MRI TechniquesRadiomics: the process and the challengesImaging biomarker roadmap for cancer studiesBolus arrival time and its effect on tissue characterization with dynamic contrast-enhanced magnetic resonance imaging.MR Imaging Biomarkers in Oncology Clinical TrialsAssessing the accuracy and reproducibility of modality independent elastography in a murine model of breast cancer.Reproducibility of quantitative indices of lung function and microstructure from 129 Xe chemical shift saturation recovery (CSSR) MR spectroscopy.Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretationInter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusionSequence design and evaluation of the reproducibility of water-selective diffusion-weighted imaging of the breast at 3 T.DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience.Quantitative Magnetization Transfer Imaging of the Breast at 3.0 T: Reproducibility in Healthy Volunteers.Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancerDynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and ExamplesEvaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer.Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model.DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibilityReproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits.Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI.Intratumor distribution and test-retest comparisons of physiological parameters quantified by dynamic contrast-enhanced MRI in rat U251 gliomaAmide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer.Dynamic contrast-enhanced imaging techniques: CT and MRIMulticentre imaging measurements for oncology and in the brain.Computerized breast mass detection using multi-scale Hessian-based analysis for dynamic contrast-enhanced MRI.Imaging in clinical trials.Dynamic contrast-enhanced MRI assessment of hyperemic fractional microvascular blood plasma volume in peripheral arterial disease: initial findings.Three-dimensional whole-liver perfusion magnetic resonance imaging in patients with hepatocellular carcinomas and colorectal hepatic metastases.The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancerDynamic contrast-enhanced MRI in clinical oncology: current status and future directions.Using dynamic contrast-enhanced magnetic resonance imaging data to constrain a positron emission tomography kinetic model: theory and simulationsReproducibility of magnetic resonance perfusion imagingSemi-quantitative parameter analysis of DCE-MRI revisited: monte-carlo simulation, clinical comparisons, and clinical validation of measurement errors in patients with type 2 neurofibromatosis.Reproducibility of CT perfusion parameters in liver tumors and normal liver.Techniques and applications of dynamic contrast enhanced magnetic resonance imaging in cancerMonitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI.Dependence of DCE-MRI biomarker values on analysis algorithm.Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation
P2860
Q24651047-7FE8741E-4391-410B-B476-FDA91D089DFCQ26768463-8481721C-F2F8-4030-ABF7-7DD4F72A5535Q26785606-755F0497-FB59-4289-8725-63928F4D02F6Q26865378-2AAEFFF8-CC9E-4B64-A5E4-5A5ABE3AE54FQ30242020-92FFCEEF-00AF-4CF3-9717-546314AB32BFQ30353922-DFDBBFEE-4085-4198-8C3B-211EAF1B4A73Q30364608-BCDA3CEA-56F4-486D-92B5-657A1B5F5A3AQ30380341-DB3942F0-7554-46FE-8F4D-9738F15BBAF1Q30489526-CC122388-0948-412E-B962-283738665041Q30575110-C6E54CB7-D621-41C6-94FE-8F10CDE73335Q30581552-9E81F434-04B1-492F-99E3-90ABC96718A4Q30822146-19192784-7096-4700-9CD3-031A2B080209Q30834578-905B6392-EEBC-4214-A429-4372FF725483Q31030824-02E33AFE-9269-4281-8FD6-5AA83AB228B9Q31154821-52DCD02C-442F-4CB1-9933-1D204168283EQ33474971-FD47CBF8-C2D5-4344-9226-5EB14122F7E0Q33510695-97B0400B-9A4F-4BE9-AE17-06A6C85379FDQ33555440-9C44CD80-8B5D-4F80-A1CD-CDCCC41C69B8Q33660443-42DEA220-B331-4208-9B75-D2435772B459Q33759248-32C862CB-AA05-4353-BDC7-5A4BB41F9C4EQ33949993-9015DF9E-D0E5-4634-8E94-E6BEB2AFEB86Q34040125-237EC8E0-AED5-4BE5-8A7A-8D6C2AA41E3CQ34160869-06313A6F-44AD-4E63-9F3E-CBF2A417F4F7Q34160964-1A6C685D-B4EE-4544-B947-55EC676F3AD2Q34203923-DFF14DB3-544D-4EA3-9CEE-768FDE3A9C59Q34203974-05741A57-A93F-4CF9-96EC-B3F629E1C947Q34226479-CEE9E533-4D61-4F5C-AEF8-BE7F04CBE646Q34256382-6A96D7C3-E567-410B-B3EB-A63EE9A9994DQ34291246-95FC5C76-7EA2-471A-BBF6-C5D3794AAB68Q34636452-4C00AEB1-08B9-439A-9228-9E3AEE9A61D9Q34776912-C85FBDA1-4F90-4F95-B658-50979563D350Q34918635-C7051EB3-4155-4D63-8AA9-E6787CA51EDBQ35039987-5E359B32-88C9-4693-958E-181D6448CD92Q35108121-47181D3F-E7C7-4B29-8E94-C61A33050CC7Q35110740-FB388093-40FB-4B5E-B28D-A96E3FF77C9DQ35167394-EA853389-E5F0-4FE3-B935-0483787CF814Q35596205-CBFD3752-4ED0-4FFB-A209-67575DC894F3Q35703167-3134FF3D-0709-4B7B-A6BC-2CCEDCF1059BQ35711964-6E353D7D-80B3-4042-A613-996DF97FBA5CQ35738413-6210C412-DD31-4BA6-8FD1-14FEBA912F64
P2860
Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Reproducibility of dynamic con ...... nd semi-quantitative analysis.
@en
type
label
Reproducibility of dynamic con ...... nd semi-quantitative analysis.
@en
prefLabel
Reproducibility of dynamic con ...... nd semi-quantitative analysis.
@en
P2093
P2860
P356
P1433
P1476
Reproducibility of dynamic con ...... and semi-quantitative analysis
@en
P2093
Anwar R Padhani
Gordon J S Rustin
J James Stirling
Martin A Lodge
N Jane Taylor
Susan M Galbraith
P2860
P304
P356
10.1002/NBM.731
P577
2002-04-01T00:00:00Z